Successfully tested Ebola vaccine

A new Ebola vaccine has just been successfully developed in the United States. Human clinical trials show safe and positive results.

Ebola vaccine is studied by GlaxoSmithKline of the UK and the National Institutes of Health (NIH). Health experts expect this to be an effective way against the Sudanese and Zaire strains of the Ebola virus, which has caused epidemic outbreaks to rob the lives of thousands of people in West Africa.

The trial was conducted at the NIH headquarters in Bethesda, Maryland. There are 20 healthy people who have been vaccinated.

The new vaccine is expected to repel the Ebola epidemic.(Photo: CBC)

According to the New England Journal of Medicine , volunteers after vaccination in the body formed antibodies against the Ebola virus. However, the researchers noted that the immunity of the participants also depends on the dose of the vaccine and may have side effects.

Clinical trials continue to be carried out in series. NIH is in talks with Liberia government officials to be allowed to carry out further tests in West Africa. Detailed information has not been disclosed.

The World Health Organization (WHO) said it hopes the vaccine trial will be conducted on more than 20,000 health workers and people in the epidemic area in West Africa in early January 2015.

'Perhaps in the risk of luck, the Ebola crisis rocked West Africa in the past year, prompting active research to find therapies as well as vaccines to prevent and soon put into production. Earlier, this work was stalled despite successful primates' experiments, said Dr. Daniel Bausch in an editorial published with the results of the Ebola vaccine.

At the same time, a Canadian-developed vaccine is also conducting clinical trials in the United States and Canada. Additional tests are also widely available in Germany, Switzerland, Gabon and Kenya.

The November 26 report by the WHO said there were 5,689 Ebola deaths, out of nearly 16,000 cases. With the exception of 15 deaths from other countries, the number of reported cases is Guinea, Sierra Leone and Liberia as the three poorest West African countries. In the past week, there have been only 600 deaths from these three countries.